CytoMed Therapeutics Limited (GDTC) has released an update.
CytoMed Therapeutics Limited is set to hold its Annual General Meeting (AGM) on May 15, 2024, in Singapore, addressing key proposals including financial statements approval, director re-elections, and auditor appointments. Shareholders are strongly encouraged to vote by proxy if they cannot attend, with a voting deadline set for May 12, 2024. Additionally, the AGM will entertain special resolutions such as the authorization to issue new shares in connection with the company’s upcoming Nasdaq listing.
For further insights into GDTC stock, check out TipRanks’ Stock Analysis page.
